Black yeasts and their filamentous relatives: Principles of pathogenesis and host defense

Clinical Microbiology Reviews

Volumn 27, Issue 3, 2014, Pages 527-542

  Seyedmousavi, Seyedmojtaba ^a,b,c   Netea, Mihai G ^a   Mouton, Johan W ^a,b   Melchers, Willem J G ^a   Verweij, Paul E ^a   de Hoog, G Sybren ^d,e,f,g,h  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^g SUN YAT SEN UNIVERSITY   (China)

^h KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTENE; CHITIN SYNTHASE; ITRACONAZOLE; MELANIN; POSACONAZOLE; VIRULENCE FACTOR; VORICONAZOLE;

ADAPTIVE IMMUNITY; ARTICLE; BLACK YEAST; CHROMOMYCOSIS; DENDRITIC CELL; ECOLOGY; FILAMENTOUS FUNGUS; HEAT TOLERANCE; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; HYDROPHOBICITY; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PATHOGENESIS; PHAEOHYPHOMYCOSIS; YEAST; ANIMAL; CLASSIFICATION; FUNGUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; MYCOSES; PATHOGENICITY; PHYSIOLOGY; TRANSMISSION; VIRULENCE;

ANIMALS; FUNGI; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOSES; VIRULENCE;

EID: 84903599622     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00093-13     Document Type: Article

References (181)

1. Matsumoto T, Ajello L, Matsuda T, Szaniszlo PJ, Walsh TJ. 1994. Developments in hyalohyphomycosis and phaeohyphomycosis. J. Med. Vet. Mycol. 32(Suppl 1):S329-S349.
2. Revankar SG, Sutton DA. 2010. Melanized fungi in human disease. Clin. Microbiol. Rev. 23:884-928. http://dx.doi.org/10.1128/CMR.00019-10.
3. Matsumoto T, Padhye AA, Ajello L. 1987. Medical significance of the so-called black yeasts. Eur. J. Epidemiol. 3:87-95.
4. Seyedmousavi S, Guillot J, de Hoog GS. 2013. Phaeohyphomycoses, emerging opportunistic diseases in animals. Clin. Microbiol. Rev. 26:19-35. http://dx.doi.org/10.1128/CMR.00065-12.
5. de Hoog GS, McGinnis MR. 1987. Ascomycetous black yeasts, p 187-199. In de Hoog GS, Smith MT, Weijman ACM (ed), The expanding realm of yeast-like fungi. Elsevier, Amsterdam, Netherlands.
6. Ruibal C, Gueidan C, Selbmann L, Gorbushina AA, Crous PW, Groenewald JZ, Muggia L, Grube M, Isola D, Schoch CL, Staley JT, Lutzoni F, de Hoog GS. 2009. Phylogeny of rock-inhabiting fungi related to Dothideomycetes. Stud. Mycol. 64:123-S7-133-S7. http://dx.doi.org/10.3114/sim.2009.64.06.
7. Matsumoto T, Cooper CR, Jr, Szaniszlo PJ. 2011. Chromoblastomycosis and phaeohyphomycosis, p 569-572. In Guerrant RL, Walker DH, Weller PF (ed), Tropical infectious diseases: principles, pathogens, and practice, 3rd ed. Elsevier, Edinburgh, United Kingdom.
8. Matsumoto T, Matsuda T, McGinnis MR, Ajello L. 1993. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses 36: 145-155.
9. Matsumoto T, Nishimoto K, Kimura K, Padhye AA, Ajello L, McGinnis MR. 1984. Phaeohyphomycosis caused by Exophiala moniliae. Sabouraudia 22:17-26. http://dx.doi.org/10.1080/00362178485380051.
10. Hachisuka H, Matsumoto T, Kusuhara M, Nomura H, Nakano S, Sasai Y. 1990. Cutaneous phaeohyphomycosis caused by Exophiala jeanselmei after renal transplantation. Int. J. Dermatol. 29:198-200. http://dx.doi.org/10.1111/j.1365-4362.1990.tb03799.x.
11. Matsumoto T, Matsuda T, McGinnis MR. 1990. A previously undescribed synanamorph of Wangiella dermatitidis. J. Med. Vet. Mycol. 28: 437-444. http://dx.doi.org/10.1080/02681219080000551.
12. Matsumoto T, Matsuda T, Padhye AA, Standard PG, Ajello L. 1992. Fungal melanonychia: ungual phaeohyphomycosis caused by Wangiella dermatitidis. Clin. Exp. Dermatol. 17:83-86. http://dx.doi.org/10.1111/j.1365-2230.1992.tb00170.x.
13. De Hoog GS, Matsumoto T, Matsuda T, Uijthof JM. 1994. Exophiala jeanselmei var. lecanii-corni, an aetiologic agent of human phaeohyphomycosis, with report of a case. J. Med. Vet. Mycol. 32:373-380. http://dx.doi.org/10.1080/02681219480000491.
14. Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak MJ, de Hoog GS. 2007. Spectrum of clinically relevant Exophiala species in the United States. J. Clin. Microbiol. 45:3713-3720. http://dx.doi.org/10.1128/JCM.02012-06.
15. Matsumoto T. 2000. Wangiella dermatitidis infections: a paradigm of the opportunistic mycoses caused by black yeasts and moulds. Kor. J. Med. Mycol. 5:45-50.
16. Suh MK. 2005. Phaeohyphomycosis in Korea. Jpn. J. Med. Mycol. 46: 67-70. http://dx.doi.org/10.3314/jjmm.46.67.
17. Matsushita A, Jilong L, Hiruma M, Kobayashi M, Matsumoto T, Ogawa H, Padhye AA. 2003. Subcutaneous phaeohyphomycosis caused by Veronaea botryosa in the People's Republic of China. J. Clin. Microbiol. 41:2219-2222. http://dx.doi.org/10.1128/JCM.41.5.2219-2222.2003.
18. Matsumoto T, Padhye AA, Ajello L, McGinnis MR. 1986. Sarcinomyces phaeomuriformis: a new dematiaceous hyphomycete. J. Med. Vet. Mycol. 24:395-400. http://dx.doi.org/10.1080/02681218680000601.
19. Takahara M, Imafuku S, Matsuda T, Uenotsuchi T, Matsumoto T, Padhye AA, Furue M. 2005. Concurrent double infections of the skin: phaeohyphomycosis and nocardiosis in a patient with idiopathic thrombocytopenic purpura. J. Am. Acad. Dermatol. 53:S277-S280. http://dx.doi.org/10.1016/j.jaad.2005.03.037.
20. Kim HU, Kang SH, Matsumoto T. 1998. Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei in a patient with advanced tuberculosis. Br. J. Dermatol. 138:351-353. http://dx.doi.org/10.1046/j.1365-2133.1998.02090.x.
21. Pappagianis D, Ajello L. 1994. Dematiaceous-a mycologic misnomer? J. Med. Vet. Mycol. 32:319-321. http://dx.doi.org/10.1080 /02681219480000401.
22. Matsumoto T, Ajello L. 1991. Dematiaceous fungi potentially pathogenic to humans and lower animals, p 117-162. In Arora DK, Ajello L, Mukerji KG (ed), Handbook of applied mycology. Marcel Dekker, New York, NY.
23. Pang KR, Wu JJ, Huang DB, Tyring SK. 2004. Subcutaneous fungal infections. Dermatol. Ther. 17:523-531. http://dx.doi.org/10.1111/j.1396-0296.2004.04056.x.
24. Matsumoto T, Ajello L. 1986. No granules, no mycetomas. Chest 90: 151-152.
25. McGinnis MR. 1980. Laboratory handbook of medical mycology. Academic Press, New York, NY.
26. Ameen M. 2009. Chromoblastomycosis: clinical presentation and management. Clin. Exp. Dermatol. 34:849-854. http://dx.doi.org/10.1111/j.1365-2230.2009.03415.x.
27. Santos AL, Palmeira VF, Rozental S, Kneipp LF, Nimrichter L, Alviano DS, Rodrigues ML, Alviano CS. 2007. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis. FEMS Microbiol. Rev. 31:570-591. http://dx.doi.org/10.1111/j.1574-6976.2007.00077.x.
28. de Hoog GS. 1993. Evolution of black yeasts: possible adaptation to the human host. Antonie Van Leeuwenhoek 63:105-109. http://dx.doi.org /10.1007/BF00872386.
29. Seyedmousavi S, Badali H, Chlebicki A, Zhao J, Prenafeta-Boldu FX, De Hoog GS. 2011. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic. Fungal Biol. 115:1030-1037. http://dx.doi.org/10.1016/j.funbio.2011.06.004.
30. McGinnis MR. 1983. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J. Am. Acad. Dermatol. 8:1-16. http://dx.doi.org/10.1016/S0190-9622(83)70001-0.
31. Ajello L. 1986. Hyalohyphomycosis and phaeohyphomycosis: two global disease entities of public health importance. Eur. J. Epidemiol. 2:243-251. http://dx.doi.org/10.1007/BF00419488.
32. Salfelder K. 1990. Atlas of fungal pathology. Kluwer Academic Publishers, Dordrecht, Netherlands.
33. Matsumoto T, Padhye AA, Ajello L, Standard P, McGinnis MR. 1984. Critical review of human isolates of Wangiella dermatitidis. Mycologia 76:232-239. http://dx.doi.org/10.2307/3793099.
34. Benaoudia F, Assouline M, Pouliquen Y, Bouvet A, Gueho E. 1999. Exophiala (Wangiella) dermatitidis keratitis after keratoplasty. Med. Mycol. 37:53-56. http://dx.doi.org/10.1080/02681219980000071.
35. Yamamoto N, Matsumoto T, Ishibashi Y. 2001. Fungal keratitis caused by Colletotrichum gloeosporioides. Cornea 20:902-903. http://dx.doi.org/10.1097/00003226-200111000-00027.
36. Vicente VA, Attili-Angelis D, Pie MR, Queiroz-Telles F, Cruz LM, Najafzadeh MJ, de Hoog GS, Zhao J, Pizzirani-Kleiner A. 2008. Environmental isolation of black yeast-like fungi involved in human infection. Stud. Mycol. 61:137-144. http://dx.doi.org/10.3114/sim.2008.61.14.
37. de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, Padin-Gonzalez C, Burger E, Badali H, Richard-Yegres N, van den Ende AH. 2007. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud. Mycol. 58:219-234. http://dx.doi.org/10.3114/sim.2007.58.08.
38. De Hoog GS, Queiroz-Telles F, Haase G, Fernandez-Zeppenfeldt G, Attili Angelis D, Gerrits Van Den Ende AH, Matos T, Peltroche-Llacsahuanga H, Pizzirani-Kleiner AA, Rainer J, Richard-Yegres N, Vicente V, Yegres F. 2000. Black fungi: clinical and pathogenic approaches. Med. Mycol. 38(Suppl 1):S243-S250.
39. Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, Zundorf J, Lutticken R, Haase G. 1999. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils. Infect. Immun. 67:94-101.
40. Polak A. 1990. Melanin as a virulence factor in pathogenic fungi. Mycoses 33:215-224.
41. Dixon DM, Migliozzi J, Cooper CR, Jr, Solis O, Breslin B, Szaniszlo PJ. 1992. Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies. Mycoses 35:17-21.
42. Dixon DM, Szaniszlo PJ, Polak A. 1991. Dihydroxynaphthalene (DHN) melanin and its relationship with virulence in the early stages of phaeohyphomycosis, p 297-318. In Cole GT, Hoch HC (ed), Fungal spore and disease initiation in plants. Plenum Press, New York, NY.
43. Szaniszlo PJ. 2006. Virulence factors in black molds with emphasis on melanin, chitin, and Wangiella as a molecularly tractable model, p 407-428. In Heitman J, Filler SG, Edwards JE, Mitchell AP (ed), Molecular principles of fungal pathogenesis. ASM Press, Washington, DC.
44. Wheeler MH, Abramczyk D, Puckhaber LS, Naruse M, Ebizuka Y, Fujii I, Szaniszlo PJ. 2008. New biosynthetic step in the melanin pathway of Wangiella (Exophiala) dermatitidis: evidence for 2-acetyl-1,3,6,8-tetrahydroxynaphthalene as a novel precursor. Eukaryot. Cell 7:1699-1711. http://dx.doi.org/10.1128/EC.00179-08.
45. Szaniszlo PJ. 2002. Molecular genetic studies of the model dematiaceous pathogen Wangiella dermatitidis. Int. J. Med. Microbiol. 292:381-390. http://dx.doi.org/10.1078/1438-4221-00221.
46. Nosanchuk JD, Casadevall A. 2006. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob. Agents Chemother. 50:3519-3528. http://dx.doi.org/10.1128/AAC.00545-06.
47. Langfelder K, Streibel M, Jahn B, Haase G, Brakhage AA. 2003. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet. Biol. 38:143-158. http://dx.doi.org/10.1016 /S1087-1845(02)00526-1.
48. Nosanchuk JD, Casadevall A. 2003. The contribution of melanin to microbial pathogenesis. Cell. Microbiol. 5:203-223. http://dx.doi.org/10.1046/j.1462-5814.2003.00268.x.
49. Zhang J, Wang L, Xi L, Huang H, Hu Y, Li X, Huang X, Lu S, Sun J. 2013. Melanin in a meristematic mutant of Fonsecaea monophora inhibits the production of nitric oxide and Th1 cytokines of murine macrophages. Mycopathologia 175:515-522. http://dx.doi.org/10.1007/s11046-012-9588-x.
50. Farbiarz SR, de Carvalho TU, Alviano C, de Souza W. 1992. Inhibitory effect of melanin on the interaction of Fonsecaea pedrosoi with mammalian cells in vitro. J. Med. Vet. Mycol. 30:265-273. http://dx.doi.org/10.1080/02681219280000351.
51. Wheeler MH, Bell AA. 1988. Melanins and their importance in pathogenic fungi. Curr. Top. Med. Mycol. 2:338-387. http://dx.doi.org/10.1007/978-1-4612-3730-3_10.
52. Polacheck I, Kwon-Chung KJ. 1988. Melanogenesis in Cryptococcus neoformans. J. Gen. Microbiol. 134:1037-1041.
53. Jacobson ES, Hove E, Emery HS. 1995. Antioxidant function of melanin in black fungi. Infect. Immun. 63:4944-4945.
54. Latge JP. 2007. The cell wall: a carbohydrate armour for the fungal cell. Mol. Microbiol. 66:279-290. http://dx.doi.org/10.1111/j.1365-2958.2007.05872.x.
55. Abramczyk D, Park C, Szaniszlo PJ. 2009. Cytolocalization of the class V chitin synthase in the yeast, hyphal and sclerotic morphotypes of Wangiella (Exophiala) dermatitidis. Fungal Genet. Biol. 46:28-41. http: //dx.doi.org/10.1016/j.fgb.2008.10.004.
56. de Nobel H, van Den Ende H, Klis FM. 2000. Cell wall maintenance in fungi. Trends Microbiol. 8:344-345. http://dx.doi.org/10.1016/S0966-842X(00)01805-9.
57. Abramczyk D, Szaniszlo PJ. 2009. Immunoaffinity purification of the class V chitin synthase of Wangiella (Exophiala) dermatitidis. Prep. Biochem. Biotechnol. 39:277-288. http://dx.doi.org/10.1080/108260609 02953244.
58. Wollenzien U, de Hoog GS, Krumbein W, Uijthof JM. 1997. Sarcinomyces petricola, a new microcolonial fungus from marble in the Mediterranean basin. Antonie Van Leeuwenhoek 71:281-288. http://dx.doi.org/10.1023/A:1000157803954.
59. Wollenzien U, de Hoog GS, Krumbein WE, Urzì C. 1995. On the isolation of microcolonial fungi occurring on and in marble and other calcareous rocks. Sci. Total Environ. 167:287-294. http://dx.doi.org/10.1016/0048-9697(95)04589-S.
60. Sterflinger K, Krumbein WE. 1997. Dematiaceous fungi as a major agent for biopitting on Mediterranean marbles and limestones. Geomicrobiol. J. 14:219-230. http://dx.doi.org/10.1080/01490459709378045.
61. Urzì C, Wollenzien U, Criseo G, Krumbein WE. 1995. Biodiversity of the rock inhabiting microflora with special reference to black fungi and black yeasts, p 289-302. In Allsopp D, Colwell RR, Hawksworth DL (ed), Diversity and ecosystem function. CAB International, Wallington, United Kingdom.
62. Selbmann L, de Hoog GS, Mazzaglia A, Friedmann EI, Onofri S. 2005. Fungi at the edge of life: cryptoendolithic black fungi from Antarctic desert. Stud. Mycol. 51:1-32.
63. Sterflinger K. 1998. Temperature and NaCl-tolerance of rock-inhabiting meristematic fungi. Antonie Van Leeuwenhoek 74:271-281. http://dx.doi.org/10.1023/A:1001753131034.
64. Wang Q, Szaniszlo PJ. 2007. WdStuAp, an APSES transcription factor, is a regulator of yeast-hyphal transitions in Wangiella (Exophiala) dermatitidis. Eukaryot. Cell 6:1595-1605. http://dx.doi.org/10.1128/EC.00037-07.
65. Mendoza L, Karuppayil SM, Szaniszlo PJ. 1993. Calcium regulates in vitro dimorphism in chromoblastomycotic fungi. Mycoses 36:157-164.
66. Haase G, Skopnik H, Groten T, Kusenbach G, Posselt HG. 1991. Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 34:373-376.
67. Ye X, Szaniszlo PJ. 2000. Expression of a constitutively active Cdc42 homologue promotes development of sclerotic bodies but represses hyphal growth in the zoopathogenic fungus Wangiella (Exophiala) dermatitidis. J. Bacteriol. 182:4941-4950. http://dx.doi.org/10.1128/JB.182.17.4941-4950.2000.
68. Nachman S, Alpan O, Malowitz R, Spitzer ED. 1996. Catheterassociated fungemia due to Wangiella (Exophiala) dermatitidis. J. Clin. Microbiol. 34:1011-1013.
69. Al-Obaid I, Ahmad S, Khan ZU, Dinesh B, Hejab HM. 2006. Catheterassociated fungemia due to Exophiala oligosperma in a leukemic child and review of fungemia cases caused by Exophiala species. Eur. J. Clin. Microbiol. Infect. Dis. 25:729-732. http://dx.doi.org/10.1007/s10096-006-0205-0.
70. Nucci M, Akiti T, Barreiros G, Silveira F, Revankar SG, Wickes BL, Sutton DA, Patterson TF. 2002. Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital water. Clin. Infect. Dis. 34:1475-1480. http://dx.doi.org/10.1086/340344.
71. de Hoog GS, Vicente VA, Najafzadeh MJ, Harrak MJ, Badali H, Seyedmousavi S. 2011. Waterborne Exophiala species causing disease in cold-blooded animals. Persoonia 27:46-72. http://dx.doi.org/10.3767 /003158511X614258.
72. Sudhadham M, Prakitsin S, Sivichai S, Chaiyarat R, Dorrestein GM, Menken SB, de Hoog GS. 2008. The neurotropic black yeast Exophiala dermatitidis has a possible origin in the tropical rain forest. Stud. Mycol. 61:145-155. http://dx.doi.org/10.3114/sim.2008.61.15.
73. Horré R, de Hoog GS. 1999. Primary cerebral infections by melanized fungi: a review. Stud. Mycol. 43:176-193.
74. Vicente VA, Orelis-Ribeiro R, Najafzadeh MJ, Sun J, Guerra RS, Miesch S, Ostrensky A, Meis JF, Klaassen CH, de Hoog GS, Boeger WA. 2012. Black yeast-like fungi associated with lethargic crab disease (LCD) in the mangrove-land crab, Ucides cordatus (Ocypodidae). Vet. Microbiol. 158:109-122. http://dx.doi.org/10.1016/j.vetmic.2012.01.031.
75. Hayakawa M, Ghosn EE, da Gloria Teixeria de Sousa M, Ferreira KS, Almeida SR. 2006. Phagocytosis, production of nitric oxide and proinflammatory cytokines by macrophages in the presence of dematiaceous [correction of dematiaceus] fungi that cause chromoblastomycosis. Scand. J. Immunol. 64:382-387. http://dx.doi.org/10.1111/j.1365-3083.2006.01804.x.
76. Satow MM, Attili-Angelis D, de Hoog GS, Angelis DF, Vicente VA. 2008. Selective factors involved in oil flotation isolation of black yeasts from the environment. Stud. Mycol. 61:157-163. http://dx.doi.org/10.3114/sim.2008.61.16.
77. Prenafeta-Boldu FX, Summerbell R, de Hoog GS. 2006. Fungi growing on aromatic hydrocarbons: biotechnology's unexpected encounter with biohazard? FEMS Microbiol. Rev. 30:109-130. http://dx.doi.org/10.1111/j.1574-6976.2005.00007.x.
78. Zhao J, Zeng J, de Hoog GS, Attili-Angelis D, Prenafeta-Boldu FX. 2010. Isolation and identification of black yeasts by enrichment on atmospheres of monoaromatic hydrocarbons. Microb. Ecol. 60:149-156. http://dx.doi.org/10.1007/s00248-010-9651-4.
79. de Hoog GS, Haase G. 1993. Nutritional physiology and selective isolation of Exophiala dermatitidis. Antonie Van Leeuwenhoek 64:17-26. http://dx.doi.org/10.1007/BF00870917.
80. Kondori N, Gilljam M, Lindblad A, Jonsson B, Moore ER, Wenneras C. 2011. High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency. J. Clin. Microbiol. 49:1004-1009. http://dx.doi.org /10.1128/JCM.01899-10.
81. Kusenbach G, Skopnik H, Haase G, Friedrichs F, Dohmen H. 1992. Exophiala dermatitidis pneumonia in cystic fibrosis. Eur. J. Pediatr. 151: 344-346. http://dx.doi.org/10.1007/BF02113255.
82. Van Dover CL, Ward ME, Scott JL, Underdown J, Anderson B, Gustafson C, Whalen M, Carnegie RB. 2007. A fungal epizootic in mussels at a deep-sea hydrothermal vent. Mar. Ecol. 28:54-62. http://dx.doi.org/10.1111/j.1439-0485.2006.00121.x.
83. Yanong RP. 2003. Fungal diseases of fish. Vet. Clin. N. Am. 6:377-400.
84. Densmore CL, Green DE. 2007. Diseases of amphibians. ILAR J. 48: 235-254. http://dx.doi.org/10.1093/ilar.48.3.235.
85. Boeger WA, Pie MR, Ostrensky A, Patella L. 2005. Lethargic crab disease: multidisciplinary evidence supports a mycotic etiology. Mem. Inst. Oswaldo Cruz 100:161-167. http://dx.doi.org/10.1590/S0074-0276 2005000200009.
86. Paré JA, Sigler L, Rosenthal KL, Mader DR. 2006. Microbiology: fungal and bacterial diseases of reptiles, p 217-239. In Mader DR (ed), Reptile medicine and surgery, vol 2. Saunders Elsevier, St Louis, MO.
87. Frank C, Vemulapalli R, Lin T. 2011. Cerebral phaeohyphomycosis due to Cladophialophora bantiana in a Huacaya alpaca (Vicugna pacos). J. Comp. Pathol. 145:410-413. http://dx.doi.org/10.1016/j.jcpa.2011.02.003.
88. Haligur M, Ozmen O, Dorrestein GM. 2010. Fatal systemic cladosporiosis in a merino sheep flock. Mycopathologia 170:411-415. http://dx.doi.org/10.1007/s11046-010-9331-4.
89. Wang X, Wang W, Lin Z, Wang X, Li T, Yu J, Liu W, Tong Z, Xu Y, Zhang J, Guan L, Dai L, Yang Y, Han W, Li R. 2014. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. J. Allergy Clin. Immunol. 133:905-908. e3. http://dx.doi.org/10.1016/j.jaci.2013.09.033.
90. Revankar SG, Sutton DA, Rinaldi MG. 2004. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin. Infect. Dis. 38: 206-216. http://dx.doi.org/10.1086/380635.
91. Sousa MG, Reid DM, Schweighoffer E, Tybulewicz V, Ruland J, Langhorne J, Yamasaki S, Taylor PR, Almeida SR, Brown GD. 2011. Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe 9:436-443. http://dx.doi.org/10.1016/j.chom.2011.04.005.
92. Romani L. 2011. Immunity to fungal infections. Nat. Rev. Immunol. 11:275-288. http://dx.doi.org/10.1038/nri2939.
93. Sotto MN, De Brito T, Silva AM, Vidal M, Castro LG. 2004. Antigen distribution and antigen-presenting cells in skin biopsies of human chromoblastomycosis. J. Cutan. Pathol. 31:14-18. http://dx.doi.org/10.1046 /j.0303-6987.2004.0131.x.
94. Rozental S, Alviano CS, de Souza W. 1994. The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages. Mycopathologia 126:85-91. http://dx.doi.org/10.1007/BF01146200.
95. Bocca AL, Brito PP, Figueiredo F, Tosta CE. 2006. Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin. Mycopathologia 161:195-203. http://dx.doi.org/10.1007/s11046-005-0228-6.
96. da Silva JP, da Silva MB, Salgado UI, Diniz JA, Rozental S, Salgado CG. 2007. Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression. FEMS Immunol. Med. Microbiol. 50:104-111. http://dx.doi.org/10.1111/j.1574-695X.2007.00239.x.
97. Gimenes VMF, Sousa MG, Ferreira KS, Marques SG, Gonçalves AG, Santos DVCL, de Silva Azevedo CMP, Almeida SR. 2005. Cytokine and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis. Microbes Infect. 7:708-713. http://dx.doi.org/10.1016/j.micinf.2005.01.006.
98. Peltroche-Llacsahuanga H, Schnitzler N, Jentsch S, Platz A, De Hoog S, Schweizer KG, Haase G. 2003. Analyses of phagocytosis, evoked oxidative burst, and killing of black yeasts by human neutrophils: a tool for estimating their pathogenicity? Med. Mycol. 41:7-14. http://dx.doi.org/10.1080/mmy.41.1.7.14.
99. Esterre P, Queiroz-Telles F. 2006. Management of chromoblastomycosis: novel perspectives. Curr. Opin. Infect. Dis. 19:148-152. http://dx.doi.org/10.1097/01.qco.0000216625.28692.67.
100. Sousa MG, Ghosn EE, Nascimento RC, Bomfim GF, Noal V, Santiago K, de Maria Pedrozo ESAC, Marques SG, Goncalves AG, de Castro Lima Santos DW, Criado PR, Costa Martins JE, Almeida SR. 2009. Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+ T cell activation in vitro. Clin. Exp. Immunol. 156:117-125. http://dx.doi.org/10.1111/j.1365-2249.2008.03870.x.
101. Reis e Sousa C, Sher A, Kaye P. 1999. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr. Opin. Immunol. 11:392-399. http://dx.doi.org/10.1016/S0952-7915(99) 80066-1.
102. Cella M, Sallusto F, Lanzavecchia A. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10-16. http://dx.doi.org/10.1016/S0952-7915(97)80153-7.
103. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, Maraskovsky E, Shortman K. 2000. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:823-833. http://dx.doi.org/10.1084 /jem.192.6.823.
104. Kalinski P, Smits HH, Schuitemaker JH, Vieira PL, van Eijk M, de Jong EC, Wierenga EA, Kapsenberg ML. 2000. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J. Immunol. 165:1877-1881. http://dx.doi.org /10.4049/jimmunol.165.4.1877.
105. Alviano DS, Franzen AJ, Travassos LR, Holandino C, Rozental S, Ejzemberg R, Alviano CS, Rodrigues ML. 2004. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. Infect. Immun. 72: 229-237. http://dx.doi.org/10.1128/IAI.72.1.229-237.2004.
106. El-Obeid A, Hassib A, Ponten F, Westermark B. 2006. Effect of herbal melanin on IL-8: a possible role of Toll-like receptor 4 (TLR4). Biochem. Biophys. Res. Commun. 344:1200-1206. http://dx.doi.org/10.1016/j.bbrc.2006.04.035.
107. Levitz SM. 2004. Interactions of Toll-like receptors with fungi. Microbes Infect. 6:1351-1355. http://dx.doi.org/10.1016/j.micinf.2004.08.014.
108. Dennehy KM, Brown GD. 2007. The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J. Leukoc. Biol. 82:253-258. http: //dx.doi.org/10.1189/jlb.1206753.
109. Kennedy AD, Willment JA, Dorward DW, Williams DL, Brown GD, DeLeo FR. 2007. Dectin-1 promotes fungicidal activity of human neutrophils. Eur. J. Immunol. 37:467-478. http://dx.doi.org/10.1002/eji.200636653.
110. Alviano DS, Kneipp LF, Lopes AH, Travassos LR, Meyer-Fernandes JR, Rodrigues ML, Alviano CS. 2003. Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by plateletactivating factor. Res. Microbiol. 154:689-695. http://dx.doi.org/10.1016/j.resmic.2003.09.002.
111. Kurita N. 1979. Cell-mediated immune responses in mice infected with Fonsecaea pedrosoi. Mycopathologia 68:9-15. http://dx.doi.org/10.1007 /BF00490385.
112. Whitcomb MP, Jeffries CD, Weise RW. 1981. Curvularia lunata in experimental phaeohyphomycosis. Mycopathologia 75:81-88. http://dx.doi.org/10.1007/BF00505782.
113. Fuchs J, Pecher S. 1992. Partial suppression of cell mediated immunity in chromoblastomycosis. Mycopathologia 119:73-76. http://dx.doi.org /10.1007/BF00443936.
114. Ahrens J, Graybill JR, Abishawl A, Tio FO, Rinaldi MG. 1989. Experimental murine chromomycosis mimicking chronic progressive human disease. Am. J. Trop. Med. Hyg. 40:651-658.
115. d'Avila SC, Pagliari C, Duarte MI. 2003. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 156: 51-60.
116. Teixeira de Sousa MG, Ghosn EE, Almeida SR. 2006. Absence of CD4+ T cells impairs host defence of mice infected with Fonsecaea pedrosoi. Scand. J. Immunol. 64:595-600. http://dx.doi.org/10.1111/j.1365-3083.2006.01846.x.
117. Esterre P, Peyrol S, Sainte-Marie D, Pradinaud R, Grimaud JA. 1993. Granulomatous reaction and tissue remodelling in the cutaneous lesion of chromomycosis. Virchows Arch. A Pathol. Anat. Histopathol. 422: 285-291. http://dx.doi.org/10.1007/BF01608337.
118. van de Veerdonk FL, Netea MG. 2010. T-cell subsets and antifungal host defenses. Curr. Fungal Infect. Rep. 4:238-243. http://dx.doi.org/10.1007/s12281-010-0034-6.
119. Takeya K, Nomoto K, Matsumoto T, Miyake T, Himeno K. 1976. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production. Clin. Exp. Immunol. 25:497-500.
120. Woodfolk JA. 2005. Allergy and dermatophytes. Clin. Microbiol. Rev. 18:30-43. http://dx.doi.org/10.1128/CMR.18.1.30-43.2005.
121. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675-1684.
122. Roberts MT. 2005. Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment. Br. Med. Bull. 75-76:115-130. http://dx.doi.org/10.1093/bmb/ldl003.
123. Spellberg B, Edwards JE, Jr. 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32:76-102. http://dx.doi.org/10.1086/317537.
124. Gimenes VM, Criado PR, Martins JE, Almeida SR. 2006. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy. Mycopathologia 162:97-101. http://dx.doi.org/10.1007 /s11046-006-0041-x.
125. Parente JN, Talhari C, Ginter-Hanselmayer G, Schettini AP, Eiras JC, de Souza JV, Tavares R, Buzina W, Brunasso AM, Massone C. 2011. Subcutaneous phaeohyphomycosis in immunocompetent patients: two new cases caused by Exophiala jeanselmei and Cladophialophora carrionii. Mycoses 54:265-269. http://dx.doi.org/10.1111/j.1439-0507.2009.01795.x.
126. Roy SM, Wodarz D. 2012. Infection of HIV-specific CD4 T helper cells and the clonal composition of the response. J. Theor. Biol. 304:143-151. http://dx.doi.org/10.1016/j.jtbi.2012.03.015.
127. Alimonti JB, Ball TB, Fowke KR. 2003. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 84:1649-1661. http://dx.doi.org/10.1099/vir.0.19110-0.
128. van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van der Meer JW, Joosten LA, Netea MG. 2009. Th17 responses and host defense against microorganisms: an overview. BMB Rep. 42:776-787. http://dx.doi.org /10.5483/BMBRep.2009.42.12.776.
129. Smeekens SP, van de Veerdonk FL, Kullberg BJ, Netea MG. 2013. Genetic susceptibility to Candida infections. EMBO Mol. Med. 5:805-813. http://dx.doi.org/10.1002/emmm.201201678.
130. Vidal MS, Castro LG, Cavalcante SC, Lacaz CS. 2004. Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi. Med. Mycol. 42:511-515. http://dx.doi.org/10.1080/13693780 310001654337.
131. Esterre P, Jahevitra M, Andriantsimahavandy A. 2000. Humoral immune response in chromoblastomycosis during and after therapy. Clin. Diagn. Lab. Immunol. 7:497-500. http://dx.doi.org/10.1128/CDLI.7.3.497-500.2000.
132. Esterre P, Jahevitra M, Ramarcel E, Andriantsimahavandy A. 1997. Evaluation of the ELISA technique for the diagnosis and the seroepidemiology of chromoblastomycosis. J. Mycol. Med. 7:137-141.
133. Nimrichter L, Cerqueira MD, Leitao EA, Miranda K, Nakayasu ES, Almeida SR, Almeida IC, Alviano CS, Barreto-Bergter E, Rodrigues ML. 2005. Structure, cellular distribution, antigenicity, and biological functions of Fonsecaea pedrosoi ceramide monohexosides. Infect. Immun. 73:7860-7868. http://dx.doi.org/10.1128/IAI.73.12.7860-7868.2005.
134. Galperin C, Shoenfeld Y, Gilburd B, Esterre P, Meroni PL, Del Papa N, Halpern GM, Andriantsimahavandy A, Gershwin ME. 1996. Antineutrophil cytoplasmic antibodies in patients with chromomycosis. Clin. Exp. Rheumatol. 14:479-483.
135. Basilio FM, Hammerschmidt M, Mukai MM, Werner B, Pinheiro RL, Moritz S. 2012. Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy. An. Bras. Dermatol. 87:767-771. http://dx.doi.org /10.1590/S0365-05962012000500017.
136. Rothberg MS, Eisenbud L, Griboff S. 1989. Chronic mucocutaneous candidiasis-thymoma syndrome. A case report. Oral Surg. Oral Med. Oral Pathol. 68:411-413. http://dx.doi.org/10.1016/0030-4220(89) 90138-2.
137. Mok CC, Que TL, Tsui EY, Lam WY. 2003. Mucormycosis in systemic lupus erythematosus. Semin. Arthritis Rheum. 33:115-124. http://dx.doi.org/10.1016/S0049-0172(03)00081-7.
138. Netea MG. 2013. Training innate immunity: the changing concept of immunological memory in innate host defence. Eur. J. Clin. Invest. 43: 881-884. http://dx.doi.org/10.1111/eci.12132.
139. Matsumoto T. 1989. Mycoses, p 116-117. In Ueki H, Yaoita H (ed), A colour atlas of dermato-immunohistocytology. Wolfe Medical Publications, London, United Kingdom.
140. Balajee SA, Sigler L, Brandt ME. 2007. DNA and the classical way: identification of medically important molds in the 21st century. Med. Mycol. 45:475-490. http://dx.doi.org/10.1080/13693780701449425.
141. Ferrer C, Colom F, Frases S, Mulet E, Abad JL, Alio JL. 2001. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J. Clin. Microbiol. 39:2873-2879. http://dx.doi.org/10.1128/JCM.39.8.2873-2879.2001.
142. Zeng JS, De Hoog GS. 2008. Exophiala spinifera and its allies: diagnostics from morphology toDNAbarcoding. Med. Mycol. 46:193-208. http: //dx.doi.org/10.1080/13693780701799217.
143. Kawasaki M, Aoki M, Ishizaki H, Miyaji M, Nishimura K, Nishimoto K, Matsumoto T, De Vroey C, Negroni R, Mendonca M, Andriantsimahavandy A, Esterre P. 1999. Molecular epidemiology of Fonsecaea pedrosoi using mitochondrial DNA analysis. Med. Mycol. 37:435-440. http://dx.doi.org/10.1080/mmy.37.6.429.440.
144. Kawasaki M, Ishizaki H, Miyaji M, Nishimura K, Matsumoto T, Hombo S, Muir D. 1993. Molecular epidemiology of Cladosporium carrionii. Mycopathologia 124:149-152. http://dx.doi.org/10.1007 /BF01103731.
145. Kawasaki M, Ishizaki H, Matsumoto T, Matsuda T, Nishimura K, Miyaji M. 1999. Mitochondrial DNA analysis of Exophiala jeanselmei var. lecanii-corni and Exophiala castellanii. Mycopathologia 146:75-77. http://dx.doi.org/10.1023/A:1007057713782.
146. Corbellini VA, Scroferneker ML, Carissimi M, Santolin LD. 2006. Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoiCMMI1 grown in different culture media. Mycopathologia 162:51-55. http://dx.doi.org/10.1007/s11046-006-0034-9.
147. Brown DL. 1993. The interpretation of tests of T-cell and natural killer cell function in man, p 843-858. In Lachmann PJ, Peters SDK, Rosen FS, Walport MJ (ed), Clinical aspects of immunology. Blackwell Scientific, Boston, MA.
148. Matsumoto T, Matsuda T. 1997. Sporotrichosis, chromoblastomycosis and phaeohyphomycosis: diagnosis and treatment. Dermatol. Ther. 3:91-96.
149. Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Florl C, Lortholary O, Meletiadis J, Munoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M. 2014. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin. Microbiol. Infect. 20(Suppl 3):47-75. http://dx.doi.org/10.1111/1469-0691.12515.
150. Fothergill AW, Rinaldi MG, Sutton DA. 2009. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med. Mycol. 47:41-43. http://dx.doi.org/10.1080/13693780802512451.
151. Espinel-Ingroff A, Boyle K, Sheehan DJ. 2001. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150:101-115. http: //dx.doi.org/10.1023/A:1010954803886.
152. Koo S, Klompas M, Marty FM. 2010. Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review. Med. Mycol. 48:769-774. http://dx.doi.org/10.3109/13693780903471081.
153. Takei H, Goodman JC, Powell SZ. 2007. Cerebral phaeohyphomycosis caused by Ladophialophora bantiana and Fonsecaea monophora: report of three cases. Clin. Neuropathol. 26:21-27. http://dx.doi.org/10.5414 /NPP26021.
154. Al-Abdely HM, Alkhunaizi AM, Al-Tawfiq JA, Hassounah M, Rinaldi MG, Sutton DA. 2005. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med. Mycol. 43:91-95. http://dx.doi.org/10.1080/13693780400011 104.
155. Negroni R, Helou SH, Petri N, Robles AM, Arechavala A, Bianchi MH. 2004. Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera. Clin. Infect. Dis. 38:e15-e20. http: //dx.doi.org/10.1086/380840.
156. Calvo E, Pastor FJ, Rodriguez MM, Mayayo E, Salas V, Guarro J. 2010. Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole. Antimicrob. Agents Chemother. 54:919-923. http://dx.doi.org/10.1128/AAC.01284-09.
157. Calvo E, Pastor FJ, Guarro J. 2010. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species. J. Antimicrob. Chemother. 65:1455-1459. http://dx.doi.org/10.1093/jac /dkq171.
158. Graybill JR, Najvar LK, Johnson E, Bocanegra R, Loebenberg D. 2004. Posaconazole therapy of disseminated phaeohyphomycosis in a murine model. Antimicrob. Agents Chemother. 48:2288-2291. http://dx.doi.org/10.1128/AAC.48.6.2288-2291.2004.
159. Marine M, Pastor FJ, Guarro J. 2009. Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana. Med. Mycol. 47:45-49. http://dx.doi.org/10.1080/13693780802526 840.
160. Defaveri J, Graybill JR. 1990. Treatment of chronic murine chromoblastomycosis with the triazole SCH39304. Am. J. Trop. Med. Hyg. 42: 601-606.
161. Calvo E, Pastor FJ, Mayayo E, Hernandez P, Guarro J. 2011. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi. Antimicrob. Agents Chemother. 55:3709-3713. http://dx.doi.org/10.1128/AAC.01662-10.
162. Rivard RG, McCall S, Griffith ME, Hawley JS, Ressner RA, Borra H, Moon JE, Beckius ML, Murray CK, Hospenthal DR. 2007. Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection. Med. Mycol. 45:685-689. http://dx.doi.org/10.1080 /13693780701390157.
163. Trinh JV, Steinbach WJ, Schell WA, Kurtzberg J, Giles SS, Perfect JR. 2003. Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy. Med. Mycol. 41:339-345. http://dx.doi.org/10.1080/369378031000137369.
164. Najafzadeh MJ, Suh MK, Lee MH, Ha GY, Kim JR, Kim TH, Lee HJ, Choi JS, Meis JF, De Hoog GS. 2013. Subcutaneous phaeohyphomycosis caused by Exophiala equina, with susceptibility to eight antifungal drugs. J. Med. Microbiol. 62:797-800. http://dx.doi.org/10.1099/jmm.0.057406-0.
165. Koga T, Matsuda T, Matsumoto T, Furue M. 2003. Therapeutic approaches to subcutaneous mycoses. Am. J. Clin. Dermatol. 4:537-543. http://dx.doi.org/10.2165/00128071-200304080-00003.
166. Bonifaz A, Carrasco-Gerard E, Saul A. 2001. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 44:1-7. http://dx.doi.org/10.1046/j.1439-0507.2001.00613.x.
167. Andrade TS, Castro LG, Nunes RS, Gimenes VM, Cury AE. 2004. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents. Mycoses 47:216-221. http: //dx.doi.org/10.1111/j.1439-0507.2004.00984.x.
168. Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. 2009. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med. Mycol. 47:3-15. http://dx.doi.org/10.1080/13693780802538001.
169. Calvo E, Pastor FJ, Salas V, Mayayo E, Capilla J, Guarro J. 2012. Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii. J. Antimicrob. Chemother. 67:666-670. http://dx.doi.org/10.1093/jac/dkr537.
170. Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A. 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev. Inst. Med. Trop. Sao Paulo 47:339-346. http://dx.doi.org/10.1590/S0036-46652005000600006.
171. Bonifaz A, Paredes-Solis V, Saul A. 2004. Treating chromoblastomycosis with systemic antifungals. Expert Opin. Pharmacother. 5:247-254. http://dx.doi.org/10.1517/14656566.5.2.247.
172. Gupta AK, Taborda PR, Sanzovo AD. 2002. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil. Med. Mycol. 40:529-534. http: //dx.doi.org/10.1080/mmy.40.5.529.534.
173. Hamza SH, Mercado PJ, Skelton HG, Smith KJ. 2003. An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature. J. Cutan. Pathol. 30:340-343. http://dx.doi.org/10.1034/j.1600-0560.2003.00067.x.
174. Najafzadeh MJ, Rezusta A, Cameo MI, Zubiri ML, Yus MC, Badali H, Revillo MJ, De Hoog GS. 2010. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora. Med. Mycol. 48:390-393. http://dx.doi.org/10.3109/13693780903008813.
175. Casadevall A, Pirofski LA. 2001. Adjunctive immune therapy for fungal infections. Clin. Infect. Dis. 33:1048-1056. http://dx.doi.org/10.1086 /322710.
176. Pappas PG. 2004. Immunotherapy for invasive fungal infections: from bench to bedside. Drug Resist. Updat. 7:3-10. http://dx.doi.org/10.1016 /j.drup.2003.12.002.
177. Safdar A. 2007. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections. Clin. Microbiol. Infect. 13:1-4. http://dx.doi.org/10.1111/j.1469-0691.2006.01571.x.
178. Armstrong-James D, Teo IA, Shrivastava S, Petrou MA, Taube D, Dorling A, Shaunak S. 2010. Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients. Am. J. Transplant. 10:1796-1803. http://dx.doi.org/10.1111/j.1600-6143.2010.03094.x.
179. Armstrong-James D, Harrison TS. 2012. Immunotherapy for fungal infections. Curr. Opin. Microbiol. 15:434-439. http://dx.doi.org/10.1016/j.mib.2012.06.001.
180. McGinnis MR, Lemon SM, Walker DH, de Hoog GS, Haase G. 1999. Fatal cerebritis caused by a new species of Cladophialophora. Stud. Mycol. 43:166-171.
181. Badali H, Najafzadeh MJ, van Esbroeck M, van den Enden E, Tarazooie B, Meis JF, de Hoog GS. 2010. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med. Mycol. 48:318-327. http://dx.doi.org/10.1080/136937 80903148353.